Nurith Harpaz

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Nurith Harpaz is an author at Weizmann Institute of Science specializing in therapeutic monoclonal antibodies, refractory chronic lymphocytic leukemia, and cell-based therapeutics.

Publications per year

2017–2017

Publications

A phase I‐<scp>II</scp> clinical trial of the anti‐<scp>CD</scp>74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: <i>A patient based approach</i>

Michal Haran, Vita Mirkin, Andrei Braester et al. · British Journal of Haematology · 2017 · 35 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–1 of 1